Literature DB >> 18565244

Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.

M Ainola1, J Mandelin, M Liljeström, Y T Konttinen, J Salo.   

Abstract

OBJECTIVE: To test if the pannus tissue is characterized by a high receptor activator of nuclear factor kappaB ligand to osteoprotegerin (RANKL:OPG) ratio, which could explain local osteoclastogenesis and formation of bony erosions.
METHODS: Messenger RNA and protein expressions of RANKL and OPG in rheumatoid and osteoarthritic tissue samples were measured using quantitative real-time RT-PCR and Western blot/densitometry. Pannus and synovitis fibroblasts explanted from tissue samples were cultured in vitro without and with TNF-alpha, IL-1Beta or IL-17 and analyzed quantitatively for RANKL expression. The ability of pannus fibroblasts to induce formation of multinuclear osteoclast-like cells from human monocytes, with macrophage-colony stimulating factor (M-CSF) but without RANKL added, was tested. Histochemical staining was used to assess the eventual presence of RANKL and tartrate resistant acid phosphatase positive osteoclast-like cells at the pannus-bone interface.
RESULTS: RANKL:OPG ratios of messenger RNA (p<0.05) and protein level were high in pannus (2.06+/-0.73 and 2.2+/-0.65) compared to rheumatoid (0.62+/-0.13 and 1.31+/-0.69) and osteoarthritis (0.62+/-0.32 and 0.52+/-0.16) synovial membranes. Resting and stimulated (p dependent on the cytokine used) pannus fibroblasts produced RANKL in excess (p=0.0005) and unstimulated pannus fibroblasts also effectively induced osteoclast-like cell formation from monocytes in vitro without any exogenous RANKL added. Compatible with these findings, multinuclear osteoclasts-like cells were frequent in the fibroblast- and macrophage-rich pannus tissue at the soft tissue-to-bone interface.
CONCLUSION: The high RANKL:OPG ratio, together with close fibroblast-to-monocyte contacts in pannus tissue, probably favor local generation of bone resorbing osteoclasts at the site of erosion in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565244

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.

Authors:  Weiqiang Chen; Suan-Sin Foo; Adam Taylor; Aleksei Lulla; Andres Merits; Linda Hueston; Mark R Forwood; Nicole C Walsh; Natalie A Sims; Lara J Herrero; Suresh Mahalingam
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

2.  Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.

Authors:  Harini Raghu; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Eric S Mullins; Jonathan G Schoenecker; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

Review 3.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

4.  Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat.

Authors:  P Oelzner; S Fleissner-Richter; R Bräuer; G Hein; G Wolf; T Neumann
Journal:  Inflamm Res       Date:  2010-03-20       Impact factor: 4.575

5.  Inhibitory Effects of Cold Atmospheric Plasma on Inflammation and Tumor-Like Feature of Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis.

Authors:  Fatemeh Faramarzi; Parisa Zafari; Mina Alimohammadi; Monireh Golpour; Salman Ghaffari; Alireza Rafiei
Journal:  Inflammation       Date:  2022-06-17       Impact factor: 4.092

6.  Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.

Authors:  Weiqiang Chen; Suan-Sin Foo; Nestor E Rulli; Adam Taylor; Kuo-Ching Sheng; Lara J Herrero; Belinda L Herring; Brett A Lidbury; Rachel W Li; Nicole C Walsh; Natalie A Sims; Paul N Smith; Suresh Mahalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

7.  Effects of the Sri Lankan medicinal plant, Salacia reticulata, in rheumatoid arthritis.

Authors:  Yuusuke Sekiguchi; Hiroshi Mano; Sachie Nakatani; Jun Shimizu; Masahiro Wada
Journal:  Genes Nutr       Date:  2009-09-02       Impact factor: 5.523

Review 8.  Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis.

Authors:  Mohammed A Alghamdi; Elrashdy M Redwan
Journal:  Probiotics Antimicrob Proteins       Date:  2021-05-25       Impact factor: 4.609

9.  Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.

Authors:  Jung-Yoon Choe; Ki-Yeun Park; Sung-Hoon Park; Sang-Il Lee; Seong-Kyu Kim
Journal:  Arthritis Res Ther       Date:  2013-02-13       Impact factor: 5.156

10.  RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Authors:  Marina Stolina; Georg Schett; Denise Dwyer; Steven Vonderfecht; Scot Middleton; Diane Duryea; Efrain Pacheco; Gwyneth Van; Brad Bolon; Ulrich Feige; Debra Zack; Paul Kostenuik
Journal:  Arthritis Res Ther       Date:  2009-12-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.